An Oakland-based startup called Omicia has raised a $6.8 million series A round of venture capital, led by Artis Ventures, for a cloud service that lets doctors analyze whole human genomes in order to identify the presence of diseases. The basic service is free (while more-advanced analyses and capabilities cost $99), and the whole process takes less than 3 hours for a whole genome (or less than 1 hour for an exome). Advances in sequencing, algorithms, data storage and cloud computing have been rapidly driving down the cost of genomic analysis over the past few years, leading to an uptick of of startup activity in the space.
A data processing unit (DPU) is a hardware accelerator usually installed on commodity x86 servers in the form of a generic PCIe…Read More
“We want to be known as the best travel company in the world, not the company with best infrastructure engineers,” – CTO,…Read More
Join GigaOm analyst Enrico Signoretti and CTERA CTO Aron Brand in this one-hour live webinar as they explore file storage trends and…Watch Now
This free 45 minute webinar from GigaOm Research brings together experts in Incident Response and DevOps, featuring GigaOm analyst Michael Levan and…Watch Now
All organizations are looking to the cloud for their compute and data storage needs. Amazon AWS is, by far, the current market…Read More
There are lots of analytics platforms out there. And while they’re all vying for the same customers, they tend to break down…Watch Now